Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
69
PRVA Quote, Financials, Valuation and Earnings
Last price:
$21.23
Seasonality move
:
-2.77%
Day range:
$20.41 - $21.23
52-week range:
$18.77 - $26.51
Dividend yield:
0%
P/E ratio:
120.47x
P/S ratio:
1.30x
P/B ratio:
3.59x
Volume:
723.7K
Avg. volume:
947.3K
1-year change:
-5.14%
Market cap:
$2.6B
Revenue:
$2.1B
EPS (TTM):
$0.18
Analysts' Opinion
-
Consensus RatingPrivia Health Group, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 14 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $31.95, Privia Health Group, Inc. has an estimated upside of 50.64% from its current price of $21.21.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $25.00 representing -17.87% downside risk from its current price of $21.21.
Fair Value
-
According to the consensus of 16 analysts, Privia Health Group, Inc. has 50.64% upside to fair value with a price target of $31.95 per share.
PRVA vs. S&P 500
-
Over the past 5 trading days, Privia Health Group, Inc. has overperformed the S&P 500 by 1.69% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Privia Health Group, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Privia Health Group, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Privia Health Group, Inc. reported revenues of $541.2M.
Earnings Growth
-
Privia Health Group, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Privia Health Group, Inc. reported earnings per share of $0.07.
Enterprise value:
2.2B
EV / Invested capital:
--
Price / LTM sales:
1.30x
EV / EBIT:
64.47x
EV / Revenue:
1.04x
PEG ratio (5yr expected):
2.19x
EV / Free cash flow:
13.61x
Price / Operating cash flow:
16.97x
Enterprise value / EBITDA:
50.00x
Gross Profit (TTM):
$199.5M
Return On Assets:
2.34%
Net Income Margin (TTM):
1.4%
Return On Equity:
4.04%
Return On Invested Capital:
4%
Operating Margin:
2.08%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $1.7B | $1.7B | $2.1B | $460.9M | $541.2M | |
| Gross Profit | $155M | $169.6M | $199.5M | $46.1M | $47M | |
| Operating Income | $20.6M | $17M | $34.2M | $5.2M | $11.3M | |
| EBITDA | $27.2M | $24.3M | $44.1M | $7.1M | $13.9M | |
| Diluted EPS | $0.19 | $0.11 | $0.18 | $0.03 | $0.07 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $446.7M | $552M | $700.8M | $834.8M | $911M | |
| Total Assets | $695.6M | $804.3M | $1B | $1.1B | $1.4B | |
| Current Liabilities | $190.5M | $264.3M | $387M | $449.1M | $568.5M | |
| Total Liabilities | $245.5M | $285.3M | $401.6M | $462.3M | $606.7M | |
| Total Equity | $450.2M | $519M | $607.4M | $683.4M | $790.9M | |
| Total Debt | $43.6M | $8.5M | $5.2M | $3M | $7.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $80.8M | $109.3M | $163.4M | $74.8M | $127.5M | |
| Cash From Investing | -$48M | -$10.3M | -$181.6M | -$6.3M | -$91.3M | |
| Cash From Financing | $8.7M | $2.7M | $6.7M | $619K | $2.1M | |
| Free Cash Flow | $80.7M | $104.3M | $162.2M | $74.8M | $127.5M | |
PRVA
Sector
Market Cap
$2.6B
$23.9M
Price % of 52-Week High
80.01%
47.44%
Dividend Yield
0%
0%
Shareholder Yield
-0.3%
-1.9%
1-Year Price Total Return
-5.14%
-18.29%
Beta (5-Year)
--
0.513
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$20.58
200-day SMA
Sell
Level
$22.75
Bollinger Bands (100)
Sell
Level
21.82 - 24.2
Chaikin Money Flow
Buy
Level
29.3M
20-day SMA
Sell
Level
$21.47
Relative Strength Index (RSI14)
Sell
Level
46.17
ADX Line
Sell
Level
21.73
Williams %R
Neutral
Level
-43.4343
50-day SMA
Sell
Level
$22.23
MACD (12, 26)
Sell
Level
-0.54
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Neutral
Level
33.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.6357)
Buy
CA Score
(Annual)
Level (0.4942)
Buy
Beneish M-Score
(Annual)
Level (-2.5708)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.6239)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Privia Health Group, Inc. engages in the provision of healthcare services. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experience, and reward doctors for delivering care both in-person and via its Privia Platform, virtual care settings. The company was founded by Jeffrey Butler on November 7, 2007 and is headquartered in Arlington, VA.
Stock Forecast FAQ
In the current month, PRVA has received 14 Buy ratings 2 Hold ratings, and 0 Sell ratings. The PRVA average analyst price target in the past 3 months is $31.95.
-
Where Will Privia Health Group, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Privia Health Group, Inc. share price will rise to $31.95 per share over the next 12 months.
-
What Do Analysts Say About Privia Health Group, Inc.?
Analysts are divided on their view about Privia Health Group, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Privia Health Group, Inc. is a Sell and believe this share price will drop from its current level to $25.00.
-
What Is Privia Health Group, Inc.'s Price Target?
The price target for Privia Health Group, Inc. over the next 1-year time period is forecast to be $31.95 according to 16 Wall Street analysts, 14 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is PRVA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Privia Health Group, Inc. is a Buy. 14 of 16 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PRVA?
You can purchase shares of Privia Health Group, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Privia Health Group, Inc. shares.
-
What Is The Privia Health Group, Inc. Share Price Today?
Privia Health Group, Inc. was last trading at $21.23 per share. This represents the most recent stock quote for Privia Health Group, Inc.. Yesterday, Privia Health Group, Inc. closed at $21.21 per share.
-
How To Buy Privia Health Group, Inc. Stock Online?
In order to purchase Privia Health Group, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get PRVA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PRVA
Sector
P/E ratio
120.47x
21.37x
PEG ratio
2.19x
-0.01x
P/B ratio
3.59x
1.72x
Price / LTM sales
1.30x
1.44x
Growth Metrics
PRVA
Sector
Revenue growth
17.42%
3.44%
Earnings growth
101.72%
14.97%
Revenue (5-year growth)
21.04%
6.27%
Earnings forecast
$0.26
-$0.22
Profitability
PRVA
Sector
Profitability FY 2025
$199.5M
$2.4M
Return on invested capital
4%
-33.43%
Return on assets
2.34%
-29.45%
Return on equity
4.04%
-40.29%
Earnings Date
Last Earnings Date
Feb
26
Next Earnings Date
May
7
Estimated Next Earnings Date
May
28
Balance Sheet
PRVA
Sector
Total cash
$479.7M
$25.6M
Short term investments
--
$22.7M
Total assets
$1.4B
$70.4M
Long term debt
$7.3M
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 4
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 4
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 4
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
